Market Overview

Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders

Share:

Shareholder rights law firm Robbins Arroyo LLP is investigating
whether certain officers and directors of Pulse Biosciences, Inc.
(NasdaqCM: PLSE) breached their fiduciary duties to shareholders. On
July 31, 2018, Pulse disclosed that it had received subpoenas from the
U.S. Securities and Exchange Commission requesting documents and
information related to an investigation into trading in the company's
stock in advance of its September 2017 financing announcement. Pulse
further revealed that on July 30, 2018, the company received a letter
from Nasdaq stating that Pulse is not in compliance with Nasdaq's audit
committee requirements and has until July 27, 2019 to regain compliance.

View this information on the law firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/pulse-biosciences-inc-aug-2018/

Pulse Biosciences Shareholders Have Legal Options

If you would like more information about your rights and potential
remedies, contact attorney Leonid Kandinov at (800) 350-6003, LKandinov@robbinsarroyo.com,
or via the shareholder
information form
on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder
rights law. The firm represents individual and institutional investors
in shareholder derivative and securities class action lawsuits, and has
helped its clients realize more than $1 billion of value for themselves
and the companies in which they have invested. Sign up for our FREE
portfolio monitoring service, Stock
Watch
.

Attorney Advertising. Past results do not guarantee a similar outcome.

View Comments and Join the Discussion!